Evidence map›Paper›PMID 41727079›Full record

ArticlebioRxiv : the preprint server for biology2026

HAMMER: Hairpin-based APOBEC3A-mediated mRNA editing reporter.

Yanjun Chen, Christopher D Mullally, Bojana Stefanovska, Reuben S Harris

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yanjun ChenDepartment of Biochemistry and Structural Biology, University of Texas San Antonio, San Antonio, Texas, USA, 78229.
Christopher D MullallyDepartment of Biochemistry and Structural Biology, University of Texas San Antonio, San Antonio, Texas, USA, 78229.
Bojana StefanovskaDepartment of Biochemistry and Structural Biology, University of Texas San Antonio, San Antonio, Texas, USA, 78229.
Reuben S HarrisDepartment of Biochemistry and Structural Biology, University of Texas San Antonio, San Antonio, Texas, USA, 78229.ORCID 0000-0002-9034-9112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

APOBEC3A catalyzes cytosine-to-uracil deamination in single-stranded DNA and RNA. Physiologically, APOBEC3A functions in innate immunity and aberrant deamination is associated with cytosine mutations in enzymatically preferred YTCW substrate motifs in multiple cancers. Much less is known about the potential contribution of APOBEC3A-catalyzed RNA editing to virus and cancer evolution. Here, we present HAMMER (hairpin-based APOBEC3A-mediated mRNA editing reporter), a rapid luminescence-based cellular assay for measuring RNA editing by APOBEC3A. HAMMER reports APOBEC3A activity as a reduction in the ratio of firefly to renilla luciferase activity. Briefly, tandem renilla and firefly luciferase open reading frames are separated by an optimal APOBEC3A hairpin substrate, in which C-to-U editing of a CGA motif yields a UGA stop codon thus preventing translation of the downstream firefly luciferase reporter, without impacting the upstream renilla reporter. HAMMER activation is dose-responsive, catalytic activity-dependent, and specific to human APOBEC3A. A panel of herpesviral ribonucleotide reductase constructs was used to show that direct inhibition of APOBEC3A results in a dose-responsive recovery of firefly luciferase expression. HAMMER is therefore a scalable and easy-to-use method for quantifying cellular APOBEC3A RNA editing activity and characterizing inhibitors.

Indexed as

APOBEC3A (A3A)DNA cytosine-to-uracil deaminationDNA editinglive-cell reporter assayRNA cytosine-to-uracil deaminationRNA editingviral ribonucleotide reductase (RNR)

Identifiers

PMID41727079
PMCPMC12918910

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.